257 related articles for article (PubMed ID: 37709864)
1. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.
Chen Y; Du X; Kuppa A; Feitosa MF; Bielak LF; O'Connell JR; Musani SK; Guo X; Kahali B; Chen VL; Smith AV; Ryan KA; Eirksdottir G; Allison MA; Bowden DW; Budoff MJ; Carr JJ; Chen YI; Taylor KD; Oliveri A; Correa A; Crudup BF; Kardia SLR; Mosley TH; Norris JM; Terry JG; Rotter JI; Wagenknecht LE; Halligan BD; Young KA; Hokanson JE; Washko GR; Gudnason V; Province MA; Peyser PA; Palmer ND; Speliotes EK
Nat Genet; 2023 Oct; 55(10):1640-1650. PubMed ID: 37709864
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Association Study of NAFLD Using Electronic Health Records.
Fairfield CJ; Drake TM; Pius R; Bretherick AD; Campbell A; Clark DW; Fallowfield JA; Hayward C; Henderson NC; Joshi PK; Mills NL; Porteous DJ; Ramachandran P; Semple RK; Shaw CA; Sudlow CLM; Timmers PRHJ; Wilson JF; Wigmore SJ; Harrison EM; Spiliopoulou A
Hepatol Commun; 2022 Feb; 6(2):297-308. PubMed ID: 34535985
[TBL] [Abstract][Full Text] [Related]
3. TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.
Longo M; Meroni M; Paolini E; Erconi V; Carli F; Fortunato F; Ronchi D; Piciotti R; Sabatini S; Macchi C; Alisi A; Miele L; Soardo G; Comi GP; Valenti L; Ruscica M; Fracanzani AL; Gastaldelli A; Dongiovanni P
Cell Mol Gastroenterol Hepatol; 2022; 13(3):759-788. PubMed ID: 34823063
[TBL] [Abstract][Full Text] [Related]
4. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
Mancina RM; Dongiovanni P; Petta S; Pingitore P; Meroni M; Rametta R; Borén J; Montalcini T; Pujia A; Wiklund O; Hindy G; Spagnuolo R; Motta BM; Pipitone RM; Craxì A; Fargion S; Nobili V; Käkelä P; Kärjä V; Männistö V; Pihlajamäki J; Reilly DF; Castro-Perez J; Kozlitina J; Valenti L; Romeo S
Gastroenterology; 2016 May; 150(5):1219-1230.e6. PubMed ID: 26850495
[TBL] [Abstract][Full Text] [Related]
5. Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort.
Wang J; Conti DV; Bogumil D; Sheng X; Noureddin M; Wilkens LR; Le Marchand L; Rosen HR; Haiman CA; Setiawan VW
Hepatol Commun; 2021 Oct; 5(10):1689-1703. PubMed ID: 34558842
[TBL] [Abstract][Full Text] [Related]
6. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
7. The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
Di Sessa A; Umano GR; Cirillo G; Del Prete A; Iacomino R; Marzuillo P; Del Giudice EM
J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):69-74. PubMed ID: 29601441
[TBL] [Abstract][Full Text] [Related]
8. Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children.
Lee KJ; Moon JS; Kim NY; Ko JS
Pediatr Obes; 2022 Feb; 17(2):e12852. PubMed ID: 34490745
[TBL] [Abstract][Full Text] [Related]
9. Association Between a Polymorphism in MBOAT7 and Chronic Kidney Disease in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease.
Koo BK; An JN; Joo SK; Kim D; Lee S; Bae JM; Park JH; Kim JH; Chang MS; Kim W
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2837-2839.e2. PubMed ID: 31546054
[TBL] [Abstract][Full Text] [Related]
10. Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
Kitamoto A; Kitamoto T; Nakamura T; Ogawa Y; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Nakao K; Sekine A; Chayama K; Nakajima A; Hotta K
Endocr J; 2014; 61(7):683-9. PubMed ID: 24785259
[TBL] [Abstract][Full Text] [Related]
11. What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?
Rivera-Iñiguez I; Panduro A; Roman S; González-Aldaco K
Ann Hepatol; 2023; 28(1):100874. PubMed ID: 36371078
[TBL] [Abstract][Full Text] [Related]
12. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation.
Vujkovic M; Ramdas S; Lorenz KM; Guo X; Darlay R; Cordell HJ; He J; Gindin Y; Chung C; Myers RP; Schneider CV; Park J; Lee KM; Serper M; Carr RM; Kaplan DE; Haas ME; MacLean MT; Witschey WR; Zhu X; Tcheandjieu C; Kember RL; Kranzler HR; Verma A; Giri A; Klarin DM; Sun YV; Huang J; Huffman JE; Creasy KT; Hand NJ; Liu CT; Long MT; Yao J; Budoff M; Tan J; Li X; Lin HJ; Chen YI; Taylor KD; Chang RK; Krauss RM; Vilarinho S; Brancale J; Nielsen JB; Locke AE; Jones MB; Verweij N; Baras A; Reddy KR; Neuschwander-Tetri BA; Schwimmer JB; Sanyal AJ; Chalasani N; Ryan KA; Mitchell BD; Gill D; Wells AD; Manduchi E; Saiman Y; Mahmud N; Miller DR; Reaven PD; Phillips LS; Muralidhar S; DuVall SL; Lee JS; Assimes TL; Pyarajan S; Cho K; Edwards TL; Damrauer SM; Wilson PW; Gaziano JM; O'Donnell CJ; Khera AV; Grant SFA; Brown CD; Tsao PS; Saleheen D; Lotta LA; Bastarache L; Anstee QM; Daly AK; Meigs JB; Rotter JI; Lynch JA; ; ; ; ; Rader DJ; Voight BF; Chang KM
Nat Genet; 2022 Jun; 54(6):761-771. PubMed ID: 35654975
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
Lin YC; Chang PF; Chang MH; Ni YH
Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
[TBL] [Abstract][Full Text] [Related]
14. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
15. The genetic backgrounds in nonalcoholic fatty liver disease.
Seko Y; Yamaguchi K; Itoh Y
Clin J Gastroenterol; 2018 Apr; 11(2):97-102. PubMed ID: 29492830
[TBL] [Abstract][Full Text] [Related]
16. Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.
Jiang ZG; Tapper EB; Kim M; Connelly MA; Krawczyk SA; Yee EU; Herman MA; Mukamal KJ; Lai M
J Clin Gastroenterol; 2018; 52(5):444-451. PubMed ID: 28362682
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study.
Kang Q; Xu J; Luo H; Tan N; Chen H; Cheng R; Pan J; Han Y; Yang Y; Liu D; Xi H; Yu M; Xu X
Gene; 2022 Apr; 820():146235. PubMed ID: 35143946
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK;
J Hepatol; 2020 Sep; 73(3):505-515. PubMed ID: 32298765
[TBL] [Abstract][Full Text] [Related]
19. 3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated Hi-C, Nanopore, and RNA sequencing.
Xu L; Yin L; Qi Y; Tan X; Gao M; Peng J
Acta Pharm Sin B; 2021 Oct; 11(10):3150-3164. PubMed ID: 34729306
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility.
Xia Y; Huang CX; Li GY; Chen KH; Han L; Tang L; Luo HQ; Bao MH
Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):533-541. PubMed ID: 30824369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
